Abstract

Cohesin and CTCF are major drivers of 3D genome organization, but their role in neurons is still emerging. Here we show a prominent role for cohesin in the expression of genes that facilitate neuronal maturation and homeostasis. Unexpectedly, we observed two major classes of activity-regulated genes with distinct reliance on cohesin in mouse primary cortical neurons. Immediate early genes remained fully inducible by KCl and BDNF, and short-range enhancer-promoter contacts at the Immediate early gene Fos formed robustly in the absence of cohesin. In contrast, cohesin was required for full expression of a subset of secondary response genes characterised by long-range chromatin contacts. Cohesin-dependence of constitutive neuronal genes with key functions in synaptic transmission and neurotransmitter signaling also scaled with chromatin loop length. Our data demonstrate that key genes required for the maturation and activation of primary cortical neurons depend on cohesin for their full expression, and that the degree to which these genes rely on cohesin scales with the genomic distance traversed by their chromatin contacts.

Data availability

RNAseq and 5C data generated in this study have been deposited at Gene Expression Omnibus under accession number GSE172429

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Lesly Calderon

    MRC London Institute of Medical Sciences, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5253-7369
  2. Felix D Weiss

    Institute of Innate Immunity, University of Bonn, Bonn, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Jonathan A Beagan

    Department of Bioengineering, University of Pennsylvania, Philadelphia, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Marta S Oliveira

    MRC London Institute of Medical Sciences, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Radina Georgieva

    MRC London Institute of Medical Sciences, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Yi-Fang Wang

    MRC London Institute of Medical Sciences, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Thomas S Carroll

    Bioinformatics Resouce Center, Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Gopuraja Dharmalingam

    MRC London Institute of Medical Sciences, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Wanfeng Gong

    Department of Bioengineering, University of Pennsylvania, Philadelphia, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Kyoko Tossell

    Institute of Clinical Sciences, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Vincenzo de Paola

    Institute of Clinical Sciences, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  12. Chad Whilding

    MRC London Institute of Medical Sciences, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  13. Mark A Ungless

    MRC London Institute of Medical Sciences, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  14. Amanda G Fisher

    MRC London Institute of Medical Sciences, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  15. Jennifer E Phillips-Cremins

    Department of Bioengineering, University of Pennsylvania, Philadelphia, United States
    For correspondence
    jcremins@seas.upenn.edu
    Competing interests
    The authors declare that no competing interests exist.
  16. Matthias Merkenschlager

    Institute of Clinical Sciences, Imperial College London, London, United Kingdom
    For correspondence
    matthias.merkenschlager@lms.mrc.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2889-3288

Funding

Medical Research Council

  • Matthias Merkenschlager

Wellcome Trust (099276/Z/12/Z)

  • Matthias Merkenschlager

European Molecular Biology Organization (ALTF 1047-2012)

  • Lesly Calderon

Human Frontiers in Science Program (LT00427/2013)

  • Lesly Calderon

National Institutes of Health (1R01-MH120269)

  • Jennifer E Phillips-Cremins

National Institutes of Health (1DP1OD031253)

  • Jennifer E Phillips-Cremins

National Institutes of Health (1R01-NS114226)

  • Jennifer E Phillips-Cremins

4D Nucleome Common Fund (1U01DK127405)

  • Jennifer E Phillips-Cremins

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Jeremy J Day, University of Alabama at Birmingham, United States

Ethics

Animal experimentation: Laboratory bred mice of the appropriate genotype were maintained under SPF conditions and 12h light/dark cycle. Embryos were used to derive cells and tissues. Ethical approval was granted by the Home Office, UK, and the Imperial College London Animal Welfare and Ethical Review Body (AWERB).

Version history

  1. Preprint posted: February 24, 2021 (view preprint)
  2. Received: December 20, 2021
  3. Accepted: April 26, 2022
  4. Accepted Manuscript published: April 26, 2022 (version 1)
  5. Version of Record published: May 13, 2022 (version 2)

Copyright

© 2022, Calderon et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,834
    views
  • 600
    downloads
  • 46
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Lesly Calderon
  2. Felix D Weiss
  3. Jonathan A Beagan
  4. Marta S Oliveira
  5. Radina Georgieva
  6. Yi-Fang Wang
  7. Thomas S Carroll
  8. Gopuraja Dharmalingam
  9. Wanfeng Gong
  10. Kyoko Tossell
  11. Vincenzo de Paola
  12. Chad Whilding
  13. Mark A Ungless
  14. Amanda G Fisher
  15. Jennifer E Phillips-Cremins
  16. Matthias Merkenschlager
(2022)
Cohesin-dependence of neuronal gene expression relates to chromatin loop length
eLife 11:e76539.
https://doi.org/10.7554/eLife.76539

Share this article

https://doi.org/10.7554/eLife.76539

Further reading

    1. Biochemistry and Chemical Biology
    2. Chromosomes and Gene Expression
    Ramona Weber, Chung-Te Chang
    Research Article

    Recent findings indicate that the translation elongation rate influences mRNA stability. One of the factors that has been implicated in this link between mRNA decay and translation speed is the yeast DEAD-box helicase Dhh1p. Here, we demonstrated that the human ortholog of Dhh1p, DDX6, triggers the deadenylation-dependent decay of inefficiently translated mRNAs in human cells. DDX6 interacts with the ribosome through the Phe-Asp-Phe (FDF) motif in its RecA2 domain. Furthermore, RecA2-mediated interactions and ATPase activity are both required for DDX6 to destabilize inefficiently translated mRNAs. Using ribosome profiling and RNA sequencing, we identified two classes of endogenous mRNAs that are regulated in a DDX6-dependent manner. The identified targets are either translationally regulated or regulated at the steady-state-level and either exhibit signatures of poor overall translation or of locally reduced ribosome translocation rates. Transferring the identified sequence stretches into a reporter mRNA caused translation- and DDX6-dependent degradation of the reporter mRNA. In summary, these results identify DDX6 as a crucial regulator of mRNA translation and decay triggered by slow ribosome movement and provide insights into the mechanism by which DDX6 destabilizes inefficiently translated mRNAs.

    1. Chromosomes and Gene Expression
    Marwan Anoud, Emmanuelle Delagoutte ... Jean-Paul Concordet
    Research Article

    Tardigrades are microscopic animals renowned for their ability to withstand extreme conditions, including high doses of ionizing radiation (IR). To better understand their radio-resistance, we first characterized induction and repair of DNA double- and single-strand breaks after exposure to IR in the model species Hypsibius exemplaris. Importantly, we found that the rate of single-strand breaks induced was roughly equivalent to that in human cells, suggesting that DNA repair plays a predominant role in tardigrades’ radio-resistance. To identify novel tardigrade-specific genes involved, we next conducted a comparative transcriptomics analysis across three different species. In all three species, many DNA repair genes were among the most strongly overexpressed genes alongside a novel tardigrade-specific gene, which we named Tardigrade DNA damage Response 1 (TDR1). We found that TDR1 protein interacts with DNA and forms aggregates at high concentration suggesting it may condensate DNA and preserve chromosome organization until DNA repair is accomplished. Remarkably, when expressed in human cells, TDR1 improved resistance to Bleomycin, a radiomimetic drug. Based on these findings, we propose that TDR1 is a novel tardigrade-specific gene conferring resistance to IR. Our study sheds light on mechanisms of DNA repair helping cope with high levels of DNA damage inflicted by IR.